Search research articles
Contact Us
Filters
Showing results (1-10 of 146) with videos related to
Page
of 15
Sort By:
Rheumatology (Oxford, England)
|
March 12, 2025
Highlights from the breakout session: outcome predictors in small, large and variable vessel vasculitis
Annelies Berden, Duvuru Geetha
Nature Reviews. Nephrology
|
March 24, 2020
PEXIVAS challenges current ANCA-associated vasculitis therapy
Adam Morris, Duvuru Geetha
Best Practice & Research. Clinical Rheumatology
|
May 27, 2023
Advances in remission induction therapy for ANCA-associated vasculitis
Adam Morris, Duvuru Geetha
Kidney International Reports
|
September 5, 2022
Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
Faten Aqeel, Duvuru Geetha
Current Rheumatology Reports
|
May 6, 2024
Kidney Failure in Pauci-immune Crescentic Glomerulonephritis: Rationale for Immunosuppression to Improve Kidney Outcome
Faten Aqeel, Duvuru Geetha
Immunotargets and Therapy
|
July 30, 2016
Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
Shivani Shah, Duvuru Geetha
Current Rheumatology Reports
|
August 17, 2012
Advances in therapy for ANCA-associated vasculitis
Duvuru Geetha, Philip Seo
Kidney International
|
September 9, 2021
Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti-neutrophil cytoplasmic antibody vasculitis
Sam Kant, Duvuru Geetha
Springerplus
|
January 29, 2015
Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature
Scott M Lee, Duvuru Geetha
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 31, 2019
ANCA-Associated Vasculitis: Core Curriculum 2020
Duvuru Geetha, J Ashley Jefferson
Page
of 15
Search research articles
Search
Showing results (1-10 of 146) with videos related to
Sort By:
Page
of 15
Rheumatology (Oxford, England)
|
March 12, 2025
Highlights from the breakout session: outcome predictors in small, large and variable vessel vasculitis
Annelies Berden, Duvuru Geetha
Nature Reviews. Nephrology
|
March 24, 2020
PEXIVAS challenges current ANCA-associated vasculitis therapy
Adam Morris, Duvuru Geetha
Best Practice & Research. Clinical Rheumatology
|
May 27, 2023
Advances in remission induction therapy for ANCA-associated vasculitis
Adam Morris, Duvuru Geetha
Kidney International Reports
|
September 5, 2022
Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
Faten Aqeel, Duvuru Geetha
Current Rheumatology Reports
|
May 6, 2024
Kidney Failure in Pauci-immune Crescentic Glomerulonephritis: Rationale for Immunosuppression to Improve Kidney Outcome
Faten Aqeel, Duvuru Geetha
Immunotargets and Therapy
|
July 30, 2016
Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
Shivani Shah, Duvuru Geetha
Current Rheumatology Reports
|
August 17, 2012
Advances in therapy for ANCA-associated vasculitis
Duvuru Geetha, Philip Seo
Kidney International
|
September 9, 2021
Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti-neutrophil cytoplasmic antibody vasculitis
Sam Kant, Duvuru Geetha
Springerplus
|
January 29, 2015
Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature
Scott M Lee, Duvuru Geetha
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 31, 2019
ANCA-Associated Vasculitis: Core Curriculum 2020
Duvuru Geetha, J Ashley Jefferson
Page
of 15